Literature DB >> 28296562

Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike.

Benjamin Grabowski1, M Alexander Schmidt1, Christian Rüter1.   

Abstract

Human-pathogenic Yersinia produce plasmid-encoded Yersinia outer proteins (Yops), which are necessary to down-regulate anti-bacterial responses that constrict bacterial survival in the host. These Yops are effectively translocated directly from the bacterial into the target cell cytosol by the type III secretion system (T3SS). Cell-penetrating peptides (CPPs) in contrast are characterized by their ability to autonomously cross cell membranes and to transport cargo - independent of additional translocation systems. The recent discovery of bacterial cell-penetrating effector proteins (CPEs) - with the prototype being the T3SS effector protein YopM - established a new class of autonomously translocating immunomodulatory proteins. CPEs represent a vast source of potential self-delivering, anti-inflammatory therapeutics. In this review, we give an update on the characteristic features of the plasmid-encoded Yops and, based on recent findings, propose the further development of these proteins for potential therapeutic applications as natural or artificial cell-penetrating forms of Yops might be of value as bacteria-derived biologics.

Entities:  

Keywords:  Yersinia outer proteins; Yop; auto-inflammatory disease; cell-penetrating effector protein; immunomodulatory; type 3 secretion system

Mesh:

Substances:

Year:  2017        PMID: 28296562      PMCID: PMC5711447          DOI: 10.1080/21505594.2017.1303588

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  244 in total

1.  YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction.

Authors:  Charles R Sweet; Joseph Conlon; Douglas T Golenbock; Jon Goguen; Neal Silverman
Journal:  Cell Microbiol       Date:  2007-06-30       Impact factor: 3.715

Review 2.  'Drugs from bugs': bacterial effector proteins as promising biological (immune-) therapeutics.

Authors:  Christian Rüter; Philip R Hardwidge
Journal:  FEMS Microbiol Lett       Date:  2013-12-11       Impact factor: 2.742

3.  Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice.

Authors:  Andreas Sing; Andreas Roggenkamp; Anna M Geiger; Jürgen Heesemann
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

4.  The Yersinia Yops inhibit invasion of Listeria, Shigella and Edwardsiella but not Salmonella into epithelial cells.

Authors:  J Mecsas; B Raupach; S Falkow
Journal:  Mol Microbiol       Date:  1998-06       Impact factor: 3.501

5.  Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia.

Authors:  K L Guan; J E Dixon
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

6.  Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells.

Authors:  R R Isberg; J M Leong
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

7.  LcrV plague vaccine with altered immunomodulatory properties.

Authors:  Katie A Overheim; R William Depaolo; Kristin L Debord; Elizabeth M Morrin; Debra M Anderson; Nathaniel M Green; Robert R Brubaker; Bana Jabri; Olaf Schneewind
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

8.  Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.

Authors:  Z Chen; J Hagler; V J Palombella; F Melandri; D Scherer; D Ballard; T Maniatis
Journal:  Genes Dev       Date:  1995-07-01       Impact factor: 11.361

9.  The Cys(X)5Arg catalytic motif in phosphoester hydrolysis.

Authors:  Z Y Zhang; Y Wang; L Wu; E B Fauman; J A Stuckey; H L Schubert; M A Saper; J E Dixon
Journal:  Biochemistry       Date:  1994-12-27       Impact factor: 3.162

10.  The crystal structure of Pseudomonas avirulence protein AvrPphB: a papain-like fold with a distinct substrate-binding site.

Authors:  Minfeng Zhu; Feng Shao; Roger W Innes; Jack E Dixon; Zhaohui Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-23       Impact factor: 11.205

View more
  13 in total

1.  A plague of actin disassembly.

Authors:  Shoichiro Ono
Journal:  J Biol Chem       Date:  2017-05-12       Impact factor: 5.157

2.  Usurping bacterial virulence factors as self-delivery vehicles for therapeutic use.

Authors:  Rachel M Olson; Deborah M Anderson
Journal:  Virulence       Date:  2017-06-21       Impact factor: 5.882

3.  Modification of the Pulmonary MyD88 Inflammatory Response Underlies the Role of the Yersinia pestis Pigmentation Locus in Primary Pneumonic Plague.

Authors:  Rachel M Olson; Miqdad O Dhariwala; William J Mitchell; Jerod A Skyberg; Deborah M Anderson
Journal:  Infect Immun       Date:  2021-02-16       Impact factor: 3.441

4.  Yersinia pestis antibiotic resistance: a systematic review.

Authors:  Chen Lei; Suresh Kumar
Journal:  Osong Public Health Res Perspect       Date:  2022-02-18

5.  The TAL Effector AvrBs3 from Xanthomonas campestris pv. vesicatoria Contains Multiple Export Signals and Can Enter Plant Cells in the Absence of the Type III Secretion Translocon.

Authors:  Felix Scheibner; Sylvestre Marillonnet; Daniela Büttner
Journal:  Front Microbiol       Date:  2017-11-09       Impact factor: 5.640

Review 6.  Staying out or Going in? The Interplay between Type 3 and Type 5 Secretion Systems in Adhesion and Invasion of Enterobacterial Pathogens.

Authors:  Rachel Whelan; Gareth McVicker; Jack C Leo
Journal:  Int J Mol Sci       Date:  2020-06-08       Impact factor: 5.923

Review 7.  Bacterial riboswitches and RNA thermometers: Nature and contributions to pathogenesis.

Authors:  Jameel M Abduljalil
Journal:  Noncoding RNA Res       Date:  2018-04-12

8.  LcrQ Coordinates with the YopD-LcrH Complex To Repress lcrF Expression and Control Type III Secretion by Yersinia pseudotuberculosis.

Authors:  Keke Fei; Huan Yan; Xiaoyan Zeng; Shaojia Huang; Wei Tang; Matthew S Francis; Shiyun Chen; Yangbo Hu
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

9.  Yersinia pestis Exploits Early Activation of MyD88 for Growth in the Lungs during Pneumonic Plague.

Authors:  Rachel M Olson; Miqdad O Dhariwala; William J Mitchell; Deborah M Anderson
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

10.  Editorial: The Pathogenic Yersiniae-Advances in the Understanding of Physiology and Virulence, Second Edition.

Authors:  Matthew S Francis; Victoria Auerbuch
Journal:  Front Cell Infect Microbiol       Date:  2019-04-18       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.